UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JAK inhibition in myelofibrosis: how to sequence treatment in this new era of multiple options

Leukemia & lymphoma, 2023-01, Vol.64 (2), p.292-299

Stein, Brady L.

2023

Volltextzugriff (PDF)

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

Blood, 2019-11, Vol.134 (22), p.1902-1911

2019

Volltextzugriff (PDF)

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

Hematology, 2019-12, Vol.2019 (1), p.397-406

2019

Volltextzugriff (PDF)

A safe and effective use of caplacizumab in pregnancy‐related acquired thrombotic thrombocytopenic purpura

British journal of haematology, 2023-08, Vol.202 (4), p.879-882

2023

Volltextzugriff (PDF)

Thrombotic and bleeding complications in classical myeloproliferative neoplasms

Seminars in thrombosis and hemostasis, 2013-02, Vol.39 (1), p.101-111

2013

Volltextzugriff (PDF)

Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials

Current hematologic malignancy reports, 2021-10, Vol.16 (5), p.483-489

Stein, Brady L.

2021

Volltextzugriff (PDF)

Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisions

Hematology, 2016-12, Vol.2016 (1), p.552-560

2016

Volltextzugriff (PDF)

Thrombocytosis and Thrombosis: Is There Really a Correlation?

Current hematologic malignancy reports, 2020-08, Vol.15 (4), p.261-267

2020

Volltextzugriff (PDF)

Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?

Journal of the National Comprehensive Cancer Network, 2018-12, Vol.16 (12), p.1539-1545

2018

Volltextzugriff (PDF)

Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery

Leukemia & lymphoma, 2017-12, Vol.58 (12), p.2786-2798

2017

Volltextzugriff (PDF)

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL

Blood, 2024-04, Vol.143 (16), p.1646-1655

2024

Volltextzugriff (PDF)

ASXL1 mutations in idiopathic cytopenias: determined significance?

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.568-570

2019

Volltextzugriff (PDF)

Central role of ULK1 in type I interferon signaling

Cell reports (Cambridge), 2015-04, Vol.11 (4), p.605-617

2015

Volltextzugriff (PDF)

Vitamin D Treatment for the Prevention of Falls in Older Adults: Systematic Review and Meta-Analysis

Journal of the American Geriatrics Society (JAGS), 2010-07, Vol.58 (7), p.1299-1310

2010

Volltextzugriff (PDF)

Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition

Nature medicine, 2015-12, Vol.21 (12), p.1473-1480

2015

Volltextzugriff (PDF)

Therapy-associated leukemic transformation in myeloproliferative neoplasms – What do we know?

Best practice & research. Clinical haematology, 2019-03, Vol.32 (1), p.65-73

2019

Volltextzugriff (PDF)

Age-related differences in disease characteristics and clinical outcomes in polycythemia vera

Leukemia & lymphoma, 2013-09, Vol.54 (9), p.1989-1995

2013

Volltextzugriff (PDF)

Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options

Annals of hematology, 2014-12, Vol.93 (12), p.1965-1976

2014

Volltextzugriff (PDF)

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F

Journal of clinical oncology, 2015-11, Vol.33 (33), p.3953-3960

2015

Volltextzugriff (PDF)

Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: Prompt resolution of anaphylaxis with the addition of avapritinib

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2021-06, Vol.9 (6), p.2534-2536

2021

Volltextzugriff (PDF)

LKB1/ STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms

Cancer discovery, 2021-06, Vol.11 (6), p.1398-1410

2021

Volltextzugriff (PDF)

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

Haematologica (Roma), 2011-10, Vol.96 (10), p.1462-1469

2011

Volltextzugriff (PDF)

Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

Thrombosis and Hemostasis in Cancer, 2019, Vol.179, p.159-178

2019

Volltextzugriff (PDF)

Chronic myeloid leukemia and risk of second malignancy in two eras of treatment

Leukemia & lymphoma, 2012-09, Vol.53 (9), p.1651-1653

Stein, Brady L.

2012

Volltextzugriff (PDF)

Long-term antithrombotic therapy after venous stent placement

Phlebology, 2020-07, Vol.35 (6), p.402-408

2020

Volltextzugriff (PDF)

1 – 25 von 307

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(287)
Mit Volltextzugriff
(244)

Publikationsform

Sprache

Englisch
(305)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

JAK inhibition in myelofibrosis: how to sequence treatment in this new era of multiple options

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

A safe and effective use of caplacizumab in pregnancy‐related acquired thrombotic thrombocytopenic purpura

Thrombotic and bleeding complications in classical myeloproliferative neoplasms

Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials

Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisions

Thrombocytosis and Thrombosis: Is There Really a Correlation?

Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?

Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery

Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL

ASXL1 mutations in idiopathic cytopenias: determined significance?

Central role of ULK1 in type I interferon signaling

Vitamin D Treatment for the Prevention of Falls in Older Adults: Systematic Review and Meta-Analysis

Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition

Therapy-associated leukemic transformation in myeloproliferative neoplasms – What do we know?

Age-related differences in disease characteristics and clinical outcomes in polycythemia vera

Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F

Systemic mastocytosis with an associated hematologic neoplasm complicated by recurrent anaphylaxis: Prompt resolution of anaphylaxis with the addition of avapritinib

LKB1/ STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes

Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

Chronic myeloid leukemia and risk of second malignancy in two eras of treatment

Long-term antithrombotic therapy after venous stent placement

Suchergebnisse filtern